Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Reliability of steroid hormone receptor assays: an international study
European Journal of Cancer and Clinical Oncology, Volume 19, No. 3, Year 1983
Notification
URL copied to clipboard!
Description
The reproducibility of oestrogen and progestin receptor assays performed by laboratories participating in an international breast cancer treatment trial has been assessed. Three tissue reference powders containing low, medium and high oestrogen receptor levels (22 ± 4, 88 ± 7, 227 ± 13 fmol/mg cytosol protein respectively) were prepared in Louisville, KY, U.S.A., assayed repeatedly and multiple samples of each shipped on solid CO2 to the coordination-distribution centre in Berne, Switzerland. Samples were dispatched from Berne to Cantons within Switzerland, to Yugoslavia, South Africa, Australia, New Zealand and also back to the United States for oestrogen and progestin receptor assays. Results were returned to Berne, Switzerland. There was a decrease in the levels of oestrogen and progestin receptors during the time of storage and transit. However, the ability to assign a powder to either the low, medium or high level of oestrogen receptor was not affected. Laboratories also determined progestin receptor. All laboratories clearly identified the powder containing the low level of progestin receptor, but there was poor quantitation with the other two assay standards. It is recommended that clinical hormone receptor laboratories, especially those participating in clinical trials, establish regular quality control procedures for both daily evaluation internally and periodic outside monitoring of interlaboratory variation. © 1983.
Authors & Co-Authors
Jordan, V. C.
Switzerland, Bern
University Hospital Bern
Zava, D. T.
Switzerland, Bern
University Hospital Bern
Eppenburger, U.
Switzerland, Basel
Universitätsspital Basel
Kiser, A.
Switzerland, Zurich
Universitatsspital Zurich
Sebek, S.
Slovenia, Ljubljana
Onkološki Inštitut Ljubljana
Dowdle, Eugene B.D.
South Africa, Cape Town
Faculty of Health Sciences
Krozowski, Zygmunt
Australia, Sydney
Royal Prince Alfred Hospital
Bennett, R. C.
Australia, Melbourne
Anti-cancer Council of Victoria
Funder, J.
Australia, Melbourne
Anti-cancer Council of Victoria
Holdaway, Ian M.
New Zealand, Auckland
Auckland City Hospital
Wittliff, J. L.
United States, Louisville
University of Louisville Health Sciences Center
Statistics
Citations: 42
Authors: 11
Affiliations: 9
Identifiers
Doi:
10.1016/0277-5379(83)90133-5
ISSN:
02775379
Research Areas
Cancer
Study Locations
South Africa